India had estimated 74 millon COVID-19 infections by August: ICMR serosurvey

The overall seroprevalence of below 10 per cent in India indicates that a large proportion of the population remains susceptible to novel coronavirus infection.

published on : 27th November 2020

Pan-India COVID-19 genome studies suggest virus genetically stable, no major mutation: Centre

Mutation typically refers to the property of a virus to undergo changes when it multiplies and the virus may develop some new strains after it replicates.

published on : 17th October 2020

Emergency use for COVID-19 vaccine to depend on trial data; roll-out of FELUDA test expected soon: Vardhan

Presently COVID-19 vaccines are in various stages of phases 1, 2 and 3 of human clinical trials, the results of which are awaited, Vardhan said during an interaction with his social media followers.

published on : 11th October 2020

DCGI nod to Phase-1 human trials of 'antisera' with potential to treat COVID-19

The 'antisera' has been developed by the Indian Council of Medical Research (ICMR) in collaboration with a Hyderabad-based bio-pharmaceutical firm.

published on : 7th October 2020

India's Feluda COVID-19 test cheaper, faster alternative to RT-PCR, say scientists

Named after Satyajit Ray's famed detective, the Feluda test, which is priced at Rs 500 and can deliver a result in 45 minutes, is able to differentiate SARS-CoV-2 from other coronaviruses.

published on : 29th September 2020

In a breakthrough, US scientists publish images of coronavirus infected cells

The generated high-powered microscopic images show a large number of the virus particles on human respiratory surfaces, ready to spread infection across tissues, and to other people.

published on : 13th September 2020

Presence of antibodies may not guarantee protection from COVID-19, say scientists

The only thing that can be said with any degree of uncertainty is that antibodies is a sign that the person has already been infected with the novel coronavirus, the scientists said.

published on : 8th September 2020

Coronavirus protein redesigned in lab, may enable fast, stable vaccine production: Study

In the current study, published in the journal Science, the scientists designed a new version of this protein which can be produced up to 10 times more in cells.

published on : 24th July 2020

SARS-CoV-2 may acquire antiviral drug resistance: Experts' latest warning on coronavirus

The virus may then be exposed to the river water containing antiviral drugs, inducing antiviral selective pressures and mutations in the virus leading to antiviral drug resistance.

published on : 3rd July 2020

SARS -COV-2 extremely resilient, so beware!

The SARS-CoV-2 virus that causes the dreadful infection is extremely resilient and can survive on surfaces much longer than expected.

published on : 29th June 2020

SARS-CoV-2: Coronavirus gene behind deaths in top three states in India

The isolate sequences from Delhi which has 3.7% mortality were found to be distributed across both the major clusters and sub-clusters.s

published on : 30th May 2020

Gujarat Biotechnology Research Centre decodes 131 genome sequences of SARS-CoV-2

The research body further tweeted that scientists from all over the country were invited to analyse these genomes.

published on : 27th May 2020

Roche eyes COVID-19 antibody test launch in May

Roche said that it had developed Elecsys Anti-SARS-CoV-2 immunoassay, which using a blood sample can detect antibodies to determine the body's immune reaction to the virus that causes COVID-19.

published on : 17th April 2020